A helpful companion read on this theme is Navigating Tirzepatide Maintenance, especially if you want to think beyond the first phase of treatment
[5] [15] Indeed, the side effects associated with thiazolidinedione medications, which include osteopenia, increased fracture risk, fluid retention, congestive heart failure, bladder cancer, and long-term weight gain, have limited their adoption
Peptides play various roles in the body, including acting as hormones, neurotransmitters, and cell signalling molecules
This includes evaluating their potential to trigger immune responses, the fate of their degradation products, and their effects on normal oral tissues over time
No amount of prior authorizations or appeals will overcome a plan-level exclusion
Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health. Novo Nordisks trial was done in people with cardiovascular disease, meaning they had a previous heart attack or stroke or symptoms of peripheral artery disease clogged arteries in the arms or legs
